Literature DB >> 2303787

Antigen-reactive T cell clones restricted by mixed isotype A beta d/E alpha d class II molecules.

M Matsunaga1, K Seki, T Mineta, M Kimoto.   

Abstract

Mixed isotype A beta dE alpha d class II molecule-restricted antigen-reactive T cell clones were obtained from (BALB/c x B6E alpha d)F1 mice. These T cell clones responded to keyhole limpet hemocyanin in the presence of (BALB/c x B6E alpha d)F1 but not CBF1 APCs. Both anti-A beta d and anti-E alpha mAbs blocked the proliferative responses of these clones. The frequency of such mixed isotype A beta E alpha-restricted T cell clones in (BALB/c x B6E alpha d)F1 mice was estimated to be approximately 10% from our limiting dilution cloning. The existence of such mixed isotype class II molecule-restricted T cells would have important implications for the expansion of the T cell repertoire as well as the induction of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303787      PMCID: PMC2187720          DOI: 10.1084/jem.171.2.577

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

Review 1.  Immune response (Ir) genes of the murine major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

2.  Characterization of cell lines expressing mutant I-Ab and I-Ak molecules allows the definition of distinct serologic epitopes on A alpha and A beta polypeptides.

Authors:  B N Beck; J M Buerstedde; C J Krco; A E Nilson; C G Chase; D J McKean
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  MHC class II molecular structure--permitted pairs?

Authors:  R I Lechler
Journal:  Immunol Today       Date:  1988-03

4.  Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d and k.

Authors:  N Koch; G J Hämmerling; N Tada; S Kimura; U Hämmerling
Journal:  Eur J Immunol       Date:  1982-11       Impact factor: 5.532

5.  Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans.

Authors:  M Watanabe; T Suzuki; M Taniguchi; N Shinohara
Journal:  Transplantation       Date:  1983-12       Impact factor: 4.939

6.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

7.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

8.  Monoclonal antibody against an Ir gene product?

Authors:  E A Lerner; L A Matis; C A Janeway; P P Jones; R H Schwartz; D B Murphy
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

9.  Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation.

Authors:  M Kimoto; C G Fathman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  3 in total

1.  Loss in CD4 T-cell responses to multiple epitopes in influenza due to expression of one additional MHC class II molecule in the host.

Authors:  Jennifer L Nayak; Andrea J Sant
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

2.  Alteration of the T-cell receptor repertoire in A.CA mice expressing an Ead transgene.

Authors:  S Ishikawa; M Y Chang; B Diamond
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Presentation of antigen by mixed isotype class II molecules in normal H-2d mice.

Authors:  G Ruberti; K S Sellins; C M Hill; R N Germain; C G Fathman; A Livingstone
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.